Consumption of NSAIDs and the development of congestive heart failure in elderly patients: An underrecognized public health problem

Archives of Internal Medicine

Volumn 160, Issue 6, 2002, Pages 777-784

  Page, John ^a   Henry, David ^b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0343184105     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.6.777     Document Type: Article

References (22)

1. Brooks PM, Day RO. Non-steroidal anti-inflammatory drugs: differences and similarities, N Engl J Med. 1991;324:1716-1725.
2. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs, N Engl J Med. 1984;310:563-572.
3. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure. N Engl J Med. 1984;321:347-352.
4. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158:1108-1112.
5. Studies of Left Ventricular Dysfunction (SOLVD) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
6. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
7. Lowe J, Candlish P, Henry D, et al. Management and outcomes of congestive heart failure: a prospective study of hospitalised patients. Med J Aust. 1998;168: 115-118.
8. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham Study. N Engl J Med. 1971;285: 1441-1446.
9. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from non-aspirin non-steroidal anti-inflammatory drugs. Gastroenterology. 1993;105:1078-1088.
10. Australian Prescription Products Guide. 24th ed. Hawthorn, Victoria: Australian Pharmaceutical Publishing Co Ltd; 1995.
11. Schlesselman JJ. Case Control Studies: Design, Conduct, Analysis, New York, NY: Oxford University Press; 1982.
12. Collett D. Modelling Binary Data. London, England: Chapman & Hall; 1991.
13. NSW Inpatient Statistics Collection: Users Manual. Sydney, Australia: New South Wales Dept of Health; 1992.
14. Blyth MB, Lazarus R, Ross D, et al. Burdens and outcomes of hospitalisation for congestive heart failure. Med J Aust. 1997;167:67-70.
15. Bruzzi P, Green S, Byar D, et al. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904-914.
16. Henry D, Robertson J. Non-steroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. Gastroenterology. 1993;104:1083-1091.
17. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 1992;20:1549-1555.
18. Marantz PR, Tobin JN, Wassertheil-Smoller S, Ahn C, Steingart RM, Wexler JP. Prognosis in ischemic heart disease. Arch Intern Med. 1992;152:2433-2437.
19. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume 1 - The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1980:25.
20. Hancock L, Walsh R, Henry DA, Redman S, Sanson-Fisher R. Drug use in Australia: a community prevalence study. Med J Aust. 1992;156:759-764.
21. McManus P, Primrose J, Henry D, et al. Pattern of use of non-steroidal anti-inflammatory drugs in Australia 1990-1994. Med J Aust. 1996;164:589-592.
22. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JRI. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc Natl Acad Sci U S A. 1994;90:11693-11697.